Pain News and Research

Latest Pain News and Research

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

A recent study from the RAND Corporation, one of the country's most trusted analytic organizations, finds a current shortage of 3,800 anesthesiologists and 1,282 nurse anesthetists. However, if current trends continue, a dramatic shortage of anesthesiologists and a significant surplus of nurse anesthetists are projected by 2020.

26 Aug 2010

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Use of an experimental targeted drug to treat metastatic melanoma tumors with a specific genetic signature was successful in more than 80 percent of patients in a phase 1 clinical trial.

26 Aug 2010

Researchers to test new plantain based food product to treat Crohn's disease

Crohn's is a condition that affects one in 800 people in the UK and causes chronic intestinal inflammation, leading to pain, bleeding and diarrhoea. Researchers are working with biotechnology company, Provexis, to test a new plantain based food product that could treat patients with the disease.

26 Aug 2010

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Afferent Pharmaceuticals, a clinical-stage biopharmaceutical company developing first-in-class, small molecule compounds that target P2X3 receptors, today announced preclinical in vivo results demonstrating that an investigational P2X3 receptor antagonist reduced experimentally induced bladder hyperactivity.

26 Aug 2010

Early intervention is key to proper healing of foot pain due to sports activities

According to Donna's doctor, Kris DiNucci, DPM, FACFAS, a Fellow of the American College of Foot and Ankle Surgeons, the conditions plaguing her are common among court-playing athletes. "Because playing tennis requires quick, repetitive foot movements and continuous forefoot pressure, neuromas, (a thickening of the nerve tissue in the foot from compression) are common," DiNucci says. "In addition, those same movements can cause athletes to develop plantar fasciitis, an inflammation of the strong ligament that extends from the heel to the toes," he added.

26 Aug 2010

Plantain and broccoli fiber help in Crohn’s disease: Study

New research suggests that plant fibers in plantains and broccoli can help prevent relapses of Crohn's disease. This disease is a long term disease of the gut that is characterized by inflammation of the lining of the digestive system, with symptoms including diarrhea and abdominal pain. Crohn's disease affects between 400,000 and 600,000 people in North America. Scientists believe that rise in processed food and decrease in fibers in diet could be a reason for rise of incidence of this disease.

25 Aug 2010

Continuous boosting of natural painkiller shuts down brain cell receptor response

ERepeatedly boosting brain levels of one natural painkiller soon shuts down the brain cell receptors that respond to it, so that the painkilling effect is lost, according to a surprising new study led by Scripps Research Institute and Virginia Commonwealth University scientists. The study has important implications for drug development.

25 Aug 2010

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

Guided Therapeutics, Inc. today announced that it was awarded $1.0 million to fund the second year of a $2.5 million grant from the National Cancer Institute (NCI) announced in 2009.

25 Aug 2010

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

OXIS INTERNATIONAL, INC. is proud to announce that it will introduce the benefits of Ergothioneine to the consumer market in September 2010 via breakthrough products for joint health and healthy aging. The first products, ErgoFlex® and ErgoPlex®, will initially be marketed via a direct mail offering being developed in partnership with Creative Direct Marketing Group, the leading service provider in the direct mail sector of the direct to consumer channel.

25 Aug 2010

Study finds 15% patients experience postoperative pain after surgery

15% of patients experience more pain, physical and emotional problems a year after surgery than before their operation and 24% have less vitality, according to a study of over 400 patients published online by the British Journal of Surgery.

25 Aug 2010

New Halt System procedure for non-cancerous fibroid treatment

A new device manufactured by Northern California-based Halt Medical recently received FDA 510K clearance using a radio-frequency energy system to treat soft tissues. Fully qualified doctors insert the Halt System into targeted fibroids under ultrasound guidance. This procedure targets the core of the fibroid, by cauterizing the blood flow that feeds the fibroid, which decreases fibroid size and subsequent discomfort.

24 Aug 2010

Center For Diagnostic Imaging's new center in Avon offers interventional procedures for joint and back pain

Center for Diagnostic Imaging is pleased to announce the opening of an outpatient medical imaging and image-guided procedure center in Avon, Indiana. The new center allows CDI to better serve medical providers and patients in the western Indianapolis communities.

24 Aug 2010

Assured Pharmacy reports 20.8% increase in same store sales

OTC Stock Review announces that it has initiated coverage of Assured Pharmacy, Inc. Assured Pharmacy, a growing chain of specialty pharmacies specializing in servicing patients who live with chronic pain, just reported a 20.8 percent increase in same store sales for June 2010 versus June 2009.

24 Aug 2010

Asia's first 'custom fit knee replacement surgery' performed at Fortis Hospitals

Combining the latest technology, medical breakthroughs and personalized patient care, Fortis Hospitals Bangalore today announced Asia's first 'Custom Fit Knee Replacement Surgery' performed on a series of patients. Dr. Sanjay Pai, Chief Orthopedic Surgeon, along with his team performed this revolutionary surgery for the first time in the Asian Continent by precisely matching the size and placement of the implant specific to the patients' knee size. This procedure ensures lesser pain, less tissue damage, faster mobilization and longer lasting implant solution.

24 Aug 2010

Physiotherapy after surgery reduces pain by 50% within 3-6 months

Most patients who receive physiotherapy after surgery experience that pain is reduced by a half within a few months. Most of them are free of pain after one to two years. This is the conclusion of a thesis presented at the University of Gothenburg, Sweden.

24 Aug 2010

Multidisciplinary approach to treat neck and back pain caused by accidents, injuries

Advanced Spine and Headache Center is pleased to announce their expansion into a multidisciplinary approach for the treatment of neck and back pain caused by an auto accident, sports injury, or work related injury. "Our main objective was to integrate physical medicine, chiropractic, physical and massage therapy, and family medicine under one location," said founder Dr. Alex Meltser.

23 Aug 2010

Medical loss ratio rules for insurers could bring controversy to Sebelius' office

Once the National Association of Insurance Commissioners finalizes recommendations on insurance companies' spending on medical costs versus administrative expenses, the next stop for that proposal will be the desk of Health and Human Services Secretary Kathleen Sebelius, Politico reports.

23 Aug 2010

Physiotherapy reduces pain in patients with shoulder problems

23 Aug 2010

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

Genzyme Corporation announced today that the two-year follow-up results from the phase 2 clinical trial of its investigational therapy known as eliglustat tartrate have been accepted for publication in the journal Blood. The results have been pre-published on the journal's website and are available to subscribers.

23 Aug 2010

InSite Vision initiates Phase 1/2 clinical trial of ISV-303

InSite Vision Incorporated, a company developing novel ophthalmic therapeutics, today announced the initiation of a Phase 1/2 clinical trial of ISV-303, a topical anti-inflammatory product intended to reduce the pain and inflammation associated with ocular surgery. ISV-303 combines a low dose of the non-steroidal anti-inflammatory bromfenac with InSite Vision's proprietary DuraSite technology.

23 Aug 2010

Pain News and Research

Latest Pain News and Research

RAND Corporation study reveals shortage of anesthesiologists, nurse anesthetists

Treating metastatic melanoma tumors with specific genetic signature shows promising results

Researchers to test new plantain based food product to treat Crohn's disease

Afferent Pharmaceuticals' P2X3 receptor antagonist reduces bladder hyperactivity

Early intervention is key to proper healing of foot pain due to sports activities

Plantain and broccoli fiber help in Crohn’s disease: Study

Continuous boosting of natural painkiller shuts down brain cell receptor response

Guided Therapeutics receives fund to commercialize LightTouch for cervical cancer detection

OXIS International to introduce new ergothioneine-based products for joint health and healthy aging

Study finds 15% patients experience postoperative pain after surgery

New Halt System procedure for non-cancerous fibroid treatment

Center For Diagnostic Imaging's new center in Avon offers interventional procedures for joint and back pain

Assured Pharmacy reports 20.8% increase in same store sales

Asia's first 'custom fit knee replacement surgery' performed at Fortis Hospitals

Physiotherapy after surgery reduces pain by 50% within 3-6 months

Multidisciplinary approach to treat neck and back pain caused by accidents, injuries

Medical loss ratio rules for insurers could bring controversy to Sebelius' office

Physiotherapy reduces pain in patients with shoulder problems

Genzyme announces publication of phase 2 clinical trial results of eliglustat tartrate for Gaucher disease

InSite Vision initiates Phase 1/2 clinical trial of ISV-303

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Pain News and Research

Latest Pain News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Newsletters you may be interested in